A Phase 2a Study of Ataluren (PTC124) in Nonambulatory P

  • Day, John W (PI)

Project: Research project

Project Details

Description

A Phase 2a Study of Ataluren (PTC124) in Nonambulatory Patients with Nonsense-Mutation-Mediated Duchenne/Becker Muscular Dystrophy
StatusFinished
Effective start/end date7/20/0911/12/10

Funding

  • PTC Therapeutics, Inc.